Among children whose mothers were treated with LAM, 11.4% (4/35) had an umbilical cord HBV infection, and among children of mothers treated with TDF, this prevalence was 9.1% (3/33). This difference was not statistically significant (p = 1.000).
Nhận xét: ở nhóm trẻ có mẹ điều trị LAM có 11,4% (4/3 5) nhiễm HBV máu cuống rốn, ở nhóm trẻ có mẹ điều trị TDF tỷ lệ nhiễm HBV máu cuống rốn là 9,1% (3/3 3), sự khác biệt không có ý nghĩa thống kê (p = 1,000).